THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT. THIS DOES NOT CONSTITUTE AN INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE TO SECURITIES. THIS PUBLIC ANNOUNCEMENT IS NOT INTENDED FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY OUTSIDE INDIA

CONNPLEX CINEMAS LIMITED

(Formerly known as VCS Industries Limited)

CIN: U74110GJ2015PLC111882

Our Company was originally formed as "Fohatron Power Limited" vide registration no. 284745 under the provisions of Companies Act 2013 pursuant to Certificate of Incorporation dated September 01, 2015 issued by Registrar of Companies, Delhi. Further, the name of our Company was changed to VCS Industries Limited pursuant to fresh certificate of incorporation issued by Registrar of Companies, Delhi on February 16, 2018. The Registered office of our Company was shifted from Delhi to Gujarat w.e.f. November 18, 2019. Further the name of our Company was changed to Connplex Cinemas Limited pursuant to fresh certificate of incorporation issued by Registrar of Companies, Central Processing Centre on August 14, 2024. The Corporate Identification Number of our Company Is U74110GJ2015PLC111882. For details of change in registered office of our Company, please refer to chapter titled "History and Corporate Structure" beginning on page no. 168 of the Prospectus.

1. There is a risk that patrons may Intentionally or unintentionally cause damage to cinema screens, which may lead to financial losses and operational disruptions.

2. Inadequate audience turnout could result in a decline in revenue, adversely affecting overall profitability and disrupting business operations.

3. There is a risk of equipment breakdowns and rising costs of premium technology installations, which could result in operational disruptions, increased capital expenditure, and reduced profit margins, ultimately impacting customer satisfaction and profitability.

4. Poor management of franchise operations may result in operational inefficiencies and brand dilution which could ultimately lead to financial losses.

5. If we fail to keep up with technological advancements, it could result in operational inefficiencies and a loss of advantage in the market, which may lead to decreased profitability.

6. There is a risk that fluctuations in food and beverage sales could adversely affect overall revenue, potentially leading to financial instability and reducer profitability.

7. Changes in movie release schedules could result in resource inefficiencies and lower audience attendance, affecting operational continuity and revenue generation.

8. Our Restated Financial Statements are prepared and signed by the Peer Review Auditor who is not Statutory Auditor of our Company as required under the provisions of ICDR

9. Inability to maintain high grade standards in theaters may lead to a decline in customer satisfaction and erode our market advantage, potentially driving high-value customers away and weakening our market position.

10. There have been certain instances of regulatory non-compliances or delays or errors in the past. We may be subject to regulatory actions and penalties for any such past or future non-compliance or delays or errors and our business, financial condition and reputation may be adversely affected.

11. The Merchant Banker associated with the Issue has handled 64 public Issue out of which 2 Issue closed below Issue price on listing date below are the details;

12. Average cost of acquisition of Equity Shares held by the Promoters is mentioned below

* The average cost of acquisition of Equity Shares by our Promoters has been calculated by taking into account the amount paid by them to acquire Shares and Shares allotted to them and as reduced by amount received on sell of shares i.e. net of sale consideration is divided by net quantity of shares acquired.

This Issue was made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 229 of the SEBI ICDR Regulations and in compliance with Regulation 253 of the SEBI ICDR Regulations wherein not more than 50.00% of the Net Issue was made available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion"), provided that our Company in consultation with the BRLM allocated up to 60.00% of the QIB Portion to Anchor Investors on a discretionary basis ("Anchor Investor Portion"). One-third of the Anchor Investor Portion was reserved for domestic Mutual Funds, subject to valid Bids being received from the domestic Mutual Funds at or above the Anchor Investor Allocation Price in accordance with the SEBI ICDR Regulations. Further, 5.00% of the Net QIB Portion was made available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Portion was made available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received at or above the Issue Price. However, if the aggregate demand from Mutual Funds is less than 5.00% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to QIBs. Further, not less than 15.00% of the Net Issue was made available for allocation on a proportionate basis to Non-Institutional Investors and not less than 35.00% of the Net Issue was made available for allocation to Individual Investors in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Issue Price. All Potential Bidders, other than Anchor Investors, were required to participate in the Issue by mandatorily utilising the Application Supported by Blocked Amount ("ASBA") process by providing details of their respective ASBA Account (as defined hereinafter) in which the corresponding Bid Amounts were blocked by the Self Certified Syndicate Banks ("SCSBs") or under the UPI Mechanism, to the extent of respective Bid Amounts. Anchor Investors were not permitted to participate in the Issue through the ASBA process. For details, please refer to the chapter titled "Issue Procedure" on page 254 of the Prospectus.

The bidding for Anchor investors was opened and closed on Wednesday, August 06, 2025. The company received 10 Anchor Investors application for 17,88,000 Equity Shares. The Anchor Investor Allocation Price was finalized at Rs. 177/- per Equity Share. A total of 14,52,000 Equity Shares were allotted under the Anchor Investor portion aggregating to Rs. 25,70,04,000.

The issue (excluding Anchor Investor Portion) received 33,825 applications for 12,16,66,400 Equity Shares (before rejections and after removing Multiple/Duplicate bids, and Bid not Banked) resulting in 33.35 times subscription (including reserved portion of market maker). The Details of the total Applications received in the issue from various categories are as under:

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - National Stock Exchange of India Limited on Tuesday August 12, 2025.

1. Allocation to Individual Investors (Alter Rejections): The Basis of Allotment to the Individual Investors, who have bid at Issue Price of Rs. 177/- per equity shares, was finalized in consultation with NSE. The category was subscribed by 24.47 times i.e. for 4,14,92,800 Equity Shares, Total number of shares allotted in this category is 16,96,000 Equity Shares to 1060 successful applicants. The category wise details of the Basis of Allotment as under:

2) Allocation to Non-Institutional Investors (More than 300,000/- to 1,000,000/-) (After Rejections): The Basis of Allotment to Other than Individual Investors (More than 300,000/- to 1,000,000/-), who have bid at Issue Price of Rs. 177/- per equity shares, was finalized in consultation with NSE. The category was subscribed by 31.08 times i.e. for 75,32,800 Equity Shares. The total number of shares allotted in this category is 2,42,400 Equity Shares to 101 successful applicants. The category wise details of the Basis of Allotment are as under:

3) Allocation to Non-Institutional Investors (More than 1,000,000/-) (After Rejections): The Basis of Allotment to Other than Individual Investors (More than 1,000,000/-), who have bid at Issue Price of Rs. 177/- per equity shares was finalized in consultation with NSE. The category was subscribed by 58.96 times i.e. for 2,85,82,400 Equity Shares. The total number of shares allotted in this category is 4,84,800 Equity Shares to 202 successful applicants. The category wise details of the Basis of Allotment are as under:

4) Allocation to QIBs excluding Anchor Investors (Alter Rejections): The Basis of Allotment to QIBs, who have bid at Issue Price of Rs. 177/- per Equity Shares or above, was finalized in consultation with NSE. The category was subscribed by 44.17 times i.e for 4,27,96,800 Equity shares. The total number of shares allotted in this category is 9,68,800 Equity Shares to 34 successful applicants. The category wise details of the Basis of Allotment are as under:

5) Allocation to Anchor Investors (After Rejections): The Company in consultation with the BRLM has allotted 14,52,000 Equity Shares to 10 Anchor Investors at Anchor Investor Issue Price of Rs. 177 per Equity Shares in accordance with the SEBI ICDR Regulations. The category wise details of the Basis of Allotment areas under:

6) Allocation to Market Maker (After Rejections): The Basis of Allotment to Market Maker who have bid at Issue Price of Rs. 177/- per Equity Shares was finalized in consultation with NSE. The category was subscribed by 1.00 times i.e. for 2,56,000 Equity shares. The total number of shares allotted in this category is 2,56,000 Equity Shares. The category wise details of the Basis of Allotment are as under:

The Board of Directors of the Company on August 12, 2025, has taken on record the Basis of Allotment of Equity Shares as approved by NSE Limited and has allotted the Equity Shares to various successful bidders. The Allotment Advices-cum-Intimations and/or notices have been forwarded to the email ids and/or address of the Applicants as registered with the depositories/as filled in the application form. Further, the instructions to Self-Certified Syndicate Banks for unblocking the funds & transfer to Public Issue Account have been issued on or before August 13, 2025. In case the same is not received within two working days, investors may contact at the address given below. The equity shares allotted to the successful allottees have been uploaded on or before August 13, 2025 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company has file the Listing application with NSE Limited on August 13, 2025. The trading will commence on August 14, 2025.

The details of the allotment made would also be hosted on the website of the Registrar to the issue, MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) at www.in.mpms.mufg.com. All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Bid cum Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:

MUFG INTIME INDIA PRIVATE LIMITED
(Formerly Link Intime India Private Limited)
Address: C101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai -400 083
Tel. No.: +91-22-49186000/+91 8108114949
Email: connplex.smeipo@linkintime.co.in
Website: www.in.mpms.mufg.com
Investor Grievance Email: connplex.smeipo@linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
	On behalf of Board of Directors
	For, Connplex Cinemas Limited
	Sd/-
	Mr. Anish Tulshibhai Patel
Place: Ahmedabad, Gujarat	Managing Director
Date: August 13, 2025	DIN:07823715

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF CONNPLEX CINEMAS LIMITED.

Connplex Cinemas Limited is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make an initial public issue of its Equity Shares and has filed the Prospectus with the Registrar of Companies, Ahmedabad on August 12, 2025 and thereafter with SEBI and the Stock Exchanges. The RHP is available on the websites of SEBI at www.sebi.gov.in, website of the Company at www.theconnplex.com, the website of the BRLM to the Issue at www.beelinemb.com, the website of NSE Emerge i.e. www.nseindia.com, respectively, Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the RHP including the section titled "Risk Factors" beginning on page 23 of the Prospectus.

The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or any state securities laws in the United States, and unless so registered, and may not be issued or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in accordance with any applicable U.S. state securities laws. The Equity Shares are being Offered and sold outside the United States in 'offshore transactions' in reliance on Regulation S under the Securities Act and the applicable laws of each jurisdiction where such Offers and sales are made. There will be no public offering in the United States.